Compare Eli Lilly And Co (LLY) vs Rent the Runway Inc (RENT) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

RENT trades at $3.11, down 1.58% with a bearish technical signal. The company shows improving fundamentals with revenue growing to $306.20M in 2025 and narrowing losses from -$212M in 2022 to -$69.90M. Valuation metrics appear attractive with P/E of 0.42 and P/S of 0.17, while recent leadership changes and Q1 2026 revenue growth of 29.2% suggest operational momentum.

Despite deep negative equity and high debt levels, RENT's improving margin trends and analyst buy ratings (42% consensus) indicate potential upside. Key risks include persistent negative cash flow and competitive pressures in the rental fashion space. The stock presents a high-risk opportunity with valuation support if turnaround execution continues.